A real-world retrospective study to assess efficacy and safety of alectinib as adjuvant therapy in IB-IIIB NSCLC patients harboring ALK rearrangement - Chang, Zeng-Hao; Zhu, Teng-Fei; Ou, Wei; Jiang, Hao; Wang, Si-Yu (Frontiers in Oncology, 2024)